What is Thymia?
Thymia is a health technology company specializing in gamified artificial intelligence tools designed to identify conditions and symptoms of mental illness. By leveraging voice, movement, and behavioral data, Thymia aims to provide objective and scalable methods for mental health diagnostics. The company's focus on utilizing advanced AI and data analytics positions it at the forefront of digital health innovation, addressing a critical need for accessible and precise mental health evaluation.
How much funding has Thymia raised?
Thymia has raised a total of $2.7M across 1 funding round:
Angel/Seed
$2.7M
Angel/Seed (2023): $2.7M with participation from Entrepreneur First and Form Ventures
Key Investors in Thymia
Entrepreneur First
Entrepreneur First is an international Talent Investor that supports individuals in building technology companies, headquartered in London, UK.
Form Ventures
Form Ventures is an investment firm focused on UK startups with public policy exposure, investing up to £1 million before Series A and assisting founders in regulated markets.
What's next for Thymia?
The recent major enterprise-level funding positions Thymia for significant expansion and further development of its AI diagnostic platform. This capital infusion is expected to accelerate product refinement, broaden market reach, and potentially explore new therapeutic applications. The strategic backing suggests a clear path toward scaling operations and solidifying its market presence in the competitive health technology sector.
See full Thymia company page
